Kyntra Bio, Inc. (KYNB)
NASDAQ: KYNB · Real-Time Price · USD
7.07
-0.06 (-0.84%)
Mar 11, 2026, 1:50 PM EDT - Market open

Kyntra Bio Revenue

Kyntra Bio had revenue of $1.08M in the quarter ending September 30, 2025, with 774.80% growth. This brings the company's revenue in the last twelve months to $-118.09M. In the year 2024, Kyntra Bio had annual revenue of $29.62M, down -36.71%.

Revenue (ttm)
$-118.09M
Revenue Growth
-36.71%
P/S Ratio
3.54
Revenue / Employee
$36,880
Employees
225
Market Cap
28.60M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202429.62M-17.18M-36.71%
Dec 31, 202346.80M-93.93M-66.74%
Dec 31, 2022140.73M-94.58M-40.19%
Dec 31, 2021235.31M58.99M33.46%
Dec 31, 2020176.32M-80.26M-31.28%
Dec 31, 2019256.58M43.62M20.48%
Dec 31, 2018212.96M81.96M62.57%
Dec 31, 2017131.00M-52.19M-28.49%
Dec 31, 2016183.19M2.36M1.31%
Dec 31, 2015180.83M43.23M31.41%
Dec 31, 2014137.60M35.43M34.68%
Dec 31, 2013102.17M36.24M54.96%
Dec 31, 201265.93M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Evaxion7.53M
Cue Biopharma7.10M
Dyadic International3.34M
IGC Pharma1.11M
RenovoRx928.00K
Exicure500.00K
Hyperion DeFi345.32K
Revenue Rankings